{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:43:10Z","timestamp":1781044990034,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2016HM49"],"award-info":[{"award-number":["ZR2016HM49"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The study aimed to determine whether high sensitivity C-reactive protein to prealbumin (hs-CRP\/PAB) ratio could be used to predict in-hospital major adverse cardiac events (MACE) in patients with acute coronary syndrome (ACS). A total of 659 patients with ACS were included in the study. Patients were divided into two groups: high hs-CRP\/PAB ratio group (hs-CRP\/PAB \u22650.010) and low hs-CRP\/PAB ratio group (hs-CRP\/PAB &lt;0.010). MACE was defined as death, cardiogenic shock, re-infarction and acute heart failure. Logistic regression was performed and the receiver operating characteristic curve (ROC) was generated to evaluate the correlation of hs-CRP\/PAB ratio and MACE in patients with ACS. The occurrence rate of MACE was significantly higher in high hs-CRP\/PAB ratio group when compared with that in low hs-CRP\/PAB ratio group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Multivariable analysis determined that hs-CRP\/PAB ratio was an independent predictor of MACE (adjusted odds ratio: 1.276, 95% confidence interval: 1.106\u20131.471, <jats:italic>P<\/jats:italic>\u2009=\u20090.001). Moreover, the area under the curve value of hs-CRP\/PAB ratio for predicting MACE was higher than hs-CRP and equal to PAB. High hs-CRP\/PAB ratio was considered as a prognostic parameter of MACE in ACS patients, with the predictive power equal to PAB but greater than hs-CRP.<\/jats:p>","DOI":"10.1038\/s41598-019-48189-y","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T10:02:38Z","timestamp":1565344958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome"],"prefix":"10.1038","volume":"9","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Chen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"48189_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","volume":"372","author":"GA Roth","year":"2015","unstructured":"Roth, G. A. et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 372, 1333\u20131341 (2015).","journal-title":"N Engl J Med"},{"key":"48189_CR2","doi-asserted-by":"publisher","first-page":"FSO251","DOI":"10.4155\/fsoa-2017-0036","volume":"4","author":"S Chacko","year":"2017","unstructured":"Chacko, S., Haseeb, S., Glover, B. M., Wallbridge, D. & Harper, A. The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome. Future Sci OA 4, FSO251 (2017).","journal-title":"Future Sci OA"},{"key":"48189_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2017.04.047","volume":"243","author":"PM Chen","year":"2017","unstructured":"Chen, P. M. et al. Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome. Int J Cardiol 243, 1\u20138 (2017).","journal-title":"Int J Cardiol"},{"key":"48189_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1536\/ihj.15-197","volume":"57","author":"M Minamisawa","year":"2016","unstructured":"Minamisawa, M. et al. Comparison of inflammatory biomarkers in outpatients with prior myocardial infarction. Int Heart J 57, 11\u201317 (2016).","journal-title":"Int Heart J"},{"key":"48189_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijcard.2016.04.089","volume":"215","author":"MS Ellulu","year":"2016","unstructured":"Ellulu, M. S., Khaza\u2019ai, H., Rahmat, A., Patimah, I. & Abed, Y. Obesity can predict and promote systemic inflammation in healthy adults. Int J Cardiol 215, 318\u2013324 (2016).","journal-title":"Int J Cardiol"},{"key":"48189_CR6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jacc.2005.10.055","volume":"47","author":"M Suleiman","year":"2006","unstructured":"Suleiman, M. et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 47, 962\u2013968 (2006).","journal-title":"J Am Coll Cardiol"},{"key":"48189_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1536\/ihj.15-346","volume":"57","author":"T Soeki","year":"2016","unstructured":"Soeki, T. & Sata, M. Inflammatory biomarkers and atherosclerosis. Int Heart J 57, 134\u2013139 (2016).","journal-title":"Int Heart J"},{"key":"48189_CR8","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.ijcard.2013.01.004","volume":"168","author":"S van Diepen","year":"2013","unstructured":"van Diepen, S. et al. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. Int J Cardiol 168, 2127\u20132133 (2013).","journal-title":"Int J Cardiol"},{"key":"48189_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg, F. L. & Berk, J. L. Transthyretin (TTR) Cardiac Amyloidosis. Circulation 126, 1286\u20131300 (2012).","journal-title":"Circulation"},{"key":"48189_CR10","doi-asserted-by":"publisher","first-page":"89E","DOI":"10.1016\/j.amjcard.2008.03.007","volume":"101","author":"K Kalantar-Zadeh","year":"2008","unstructured":"Kalantar-Zadeh, K., Anker, S. D., Horwich, T. B. & Fonarow, G. C. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol 101, 89E\u2013103E (2008).","journal-title":"Am J Cardiol"},{"key":"48189_CR11","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1136\/heartjnl-2014-305747","volume":"100","author":"P Louren\u00e7o","year":"2014","unstructured":"Louren\u00e7o, P. et al. Low prealbumin is strongly associated with adverse outcome in heart failure. Heart 100, 1780\u20131785 (2014).","journal-title":"Heart"},{"key":"48189_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.ijcard.2012.09.169","volume":"166","author":"P Louren\u00e7o","year":"2013","unstructured":"Louren\u00e7o, P. et al. Does pre-albumin predict in-hospital mortality in heart failure? Int J Cardiol 166, 758\u2013760 (2013).","journal-title":"Int J Cardiol"},{"key":"48189_CR13","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1016\/j.ijcard.2013.04.039","volume":"168","author":"A Cabassi","year":"2013","unstructured":"Cabassi, A. et al. Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients. Int J Cardiol 168, 3334\u20133339 (2013).","journal-title":"Int J Cardiol"},{"key":"48189_CR14","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.12659\/MSM.902348","volume":"23","author":"C Zhang","year":"2017","unstructured":"Zhang, C. et al. Association of serum prealbumin with angiographic severity in patients with acute coronary syndrome. Med Sci Monit 23, 4041\u20134049 (2017).","journal-title":"Med Sci Monit"},{"key":"48189_CR15","doi-asserted-by":"publisher","first-page":"e11740","DOI":"10.1097\/MD.0000000000011740","volume":"97","author":"W Wang","year":"2018","unstructured":"Wang, W. et al. Low serum prealbumin levels on admission can independently predict in-hospital adverse cardiac events in patients with acute coronary syndrome. Medicine (Baltimore) 97, e11740 (2018).","journal-title":"Medicine (Baltimore)"},{"key":"48189_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2369-12-30","volume":"12","author":"Q Xie","year":"2011","unstructured":"Xie, Q. et al. The ratio of CRP to prealbumin levels predict mortality in patients with hospital-acquired acute kidney injury. BMC Nephrol 12, 30 (2011).","journal-title":"BMC Nephrol"},{"key":"48189_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.amjsurg.2010.06.021","volume":"202","author":"S Harriman","year":"2011","unstructured":"Harriman, S., Rodych, N., Hayes, P. & Moser, M. A. The C-reactive protein-to-prealbumin ratio predicts fistula closure. Am J Surg 202, 175\u2013178 (2011).","journal-title":"Am J Surg"},{"key":"48189_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2217\/bmm-2016-0266","volume":"11","author":"L Li","year":"2017","unstructured":"Li, L. et al. Predictive value of the C-reactive protein-to-prealbumin ratio in medical ICU patients. Biomark Med 11, 329\u2013337 (2017).","journal-title":"Biomark Med"},{"key":"48189_CR19","doi-asserted-by":"crossref","unstructured":"Pinilla, J. C., Hayes, P., Laverty, W., Arnold, C. & Laxdal, V. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 124, 799\u2013805; discussion 805\u2013806 (1998).","DOI":"10.1067\/msy.1998.91365"},{"key":"48189_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","volume":"104","author":"P Libby","year":"2001","unstructured":"Libby, P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104, 365\u2013372 (2001).","journal-title":"Circulation"},{"key":"48189_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/hc0802.104327","volume":"105","author":"AM Varnava","year":"2002","unstructured":"Varnava, A. M., Mills, P. G. & Davies, M. J. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 105, 939\u2013943 (2002).","journal-title":"Circulation"},{"key":"48189_CR22","doi-asserted-by":"publisher","first-page":"e0151916","DOI":"10.1371\/journal.pone.0151916","volume":"11","author":"R Li","year":"2016","unstructured":"Li, R., Chen, L. Z., Zhao, S. P. & Huang, X. S. Inflammation activation contributes to adipokine imbalance in patients with acute coronary syndrome. PLoS One 11, e0151916 (2016).","journal-title":"PLoS One"},{"key":"48189_CR23","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1681\/ASN.2006080938","volume":"17","author":"M Goicoechea","year":"2006","unstructured":"Goicoechea, M. et al. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease. J Am Soc Nephrol 17, S231\u2013235 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"48189_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ahj.2005.11.011","volume":"152","author":"D Aguilar","year":"2006","unstructured":"Aguilar, D. et al. Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J 152, 298\u2013304 (2006).","journal-title":"Am Heart J"},{"key":"48189_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","volume":"343","author":"B Lindahl","year":"2000","unstructured":"Lindahl, B., Toss, H., Siegbahn, A., Venge, P. & Wallentin, L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343, 1139\u20131147 (2000).","journal-title":"N Engl J Med"},{"key":"48189_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.amjcard.2006.07.059","volume":"99","author":"O Gach","year":"2017","unstructured":"Gach, O. et al. Long term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. Am J Cardiol 99, 31\u201335 (2017).","journal-title":"Am J Cardiol"},{"key":"48189_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijcard.2017.08.027","volume":"248","author":"HE Groot","year":"2017","unstructured":"Groot, H. E. et al. High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction. Int J Cardiol 248, 51\u201356 (2017).","journal-title":"Int J Cardiol"},{"key":"48189_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.atherosclerosis.2012.02.024","volume":"222","author":"J Cubedo","year":"2012","unstructured":"Cubedo, J. et al. Differential proteomic distribution of TTR (pre-albumin) forms in serum and HDL of patients with high cardiovascular risk. Atherosclerosis 222, 263\u2013269 (2012).","journal-title":"Atherosclerosis"},{"key":"48189_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2369-12-18","volume":"12","author":"K Zhang","year":"2011","unstructured":"Zhang, K. et al. Low levels of vitamin C in dialysis patients is associated with decreased prealbumin and increased C-reactive protein. BMC Nephrol 12, 18 (2011).","journal-title":"BMC Nephrol"},{"key":"48189_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/oxfordjournals.aje.a008957","volume":"144","author":"NR Sahyoun","year":"1996","unstructured":"Sahyoun, N. R., Jacques, P. F. & Russell, R. M. Carotenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol 144, 501\u2013511 (1996).","journal-title":"Am J Epidemiol"},{"key":"48189_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0002-9343(01)00980-9","volume":"111","author":"L Friberg","year":"2001","unstructured":"Friberg, L., Drvota, V., Bjelak, A. H., Eggertsen, G. & Ahnve, S. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med 111, 699\u2013703 (2001).","journal-title":"Am J Med"},{"key":"48189_CR32","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.clinbiochem.2008.06.016","volume":"41","author":"A Devakonda","year":"2008","unstructured":"Devakonda, A. et al. Transthyretin as a marker to predict outcome in critically ill patients. Clin Biochem 41, 1126\u20131130 (2008).","journal-title":"Clin Biochem"},{"key":"48189_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","volume":"127","author":"PT O\u2019Gara","year":"2013","unstructured":"O\u2019Gara, P. T. et al. ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 127, 529\u2013555 (2013).","journal-title":"Circulation"},{"key":"48189_CR34","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam, E. A. et al. AHA\/ACC guideline for the management of patients with non\u2500ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 130, 2354\u20132394 (2014).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48189-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:25:34Z","timestamp":1671279934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48189-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48189"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48189-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"8 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11583"}}